Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


07.05.2018

3 Ann Intern Med
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Gut
1 Hepatology
2 J Hepatol
2 J Med Virol
1 J Viral Hepat
1 J Virol
1 Lancet Gastroenterol Hepatol
1 PLoS One
1 Scand J Gastroenterol
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. NAKAMURA H, Fujieda Y, Yasuda S, Nakai M, et al
    Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus.
    Ann Intern Med. 2018 May 1. pii: 2680058. doi: 10.7326/L17-0759.
    PubMed     Text format    

  2. BELPERIO PS, Chartier M, Ross DB
    After Curing Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:682-683.
    PubMed     Text format    

  3. DEBES JD
    After Curing Hepatitis C Virus Infection.
    Ann Intern Med. 2018;168:682.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  4. STROFFOLINI T, Sagnelli E, Almasio PL, Andriulli A, et al
    Etiological factors of chronic hepatitis in Italy: a 2014 national survey.
    Eur J Gastroenterol Hepatol. 2017 May 19. doi: 10.1097/MEG.0000000000000907.
    PubMed     Text format     Abstract available


    Gastroenterology

  5. BONACCI M, Lens S, Marino Z, Londono MC, et al
    Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
    Gastroenterology. 2018 Apr 26. pii: S0016-5085(18)30485.
    PubMed     Text format     Abstract available


    Gut

  6. CACOUB P, Desbois AC, Comarmond C, Saadoun D, et al
    Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis.
    Gut. 2018 Apr 27. pii: gutjnl-2018-316234. doi: 10.1136/gutjnl-2018-316234.
    PubMed     Text format     Abstract available


    Hepatology

  7. ALAO H, Cam M, Keembiyehetty C, Zhang F, et al
    Baseline Intrahepatic and Peripheral Innate Immunity are Associated with Hepatitis C Virus Clearance During DAA Therapy.
    Hepatology. 2018 Apr 27. doi: 10.1002/hep.29921.
    PubMed     Text format     Abstract available


    J Hepatol

  8. GROEPPER C, Rufinatscha K, Schroder N, Stindt S, et al
    HCV modifies EGF signalling and upregulates production of CXCR2 ligands: role in inflammation and antiviral immune response.
    J Hepatol. 2018 Apr 26. pii: S0168-8278(18)32013.
    PubMed     Text format     Abstract available

  9. BLOOM S, Kemp W, Nicoll A, Roberts SK, et al
    Liver Stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver related events in hepatitis C.
    J Hepatol. 2018 Apr 27. pii: S0168-8278(18)32023.
    PubMed     Text format     Abstract available


    J Med Virol

  10. ALEM SA, Said M, Anwar I, Abdellatif Z, et al
    Improvement of LSM, ARFI measurements and non-invasive fibrosis markers after DAAs for HCV G4 recurrence post living donor liver transplantation: Egyptian cohort.
    J Med Virol. 2018 May 2. doi: 10.1002/jmv.25210.
    PubMed     Text format     Abstract available

  11. DE DIEU LONGO J, Bouassa RM, Simaleko MM, Kouabosso A, et al
    Usefulness of simultaneous screening for HIV- and HCV- specific antibodies and HBsAg by capillary-based multiplex rapid diagnostic test to strengthen linkage-to-care in sub-Saharan patients attending sexually transmitted infections clinic.
    J Med Virol. 2018 May 2. doi: 10.1002/jmv.25209.
    PubMed     Text format     Abstract available


    J Viral Hepat

  12. DASHTSEREN B, Bungert A, Bat-Ulzii P, Enkhbat M, et al
    Endemic prevalence of hepatitis B and C in Mongolia: A nationwide survey among Mongolian adults.
    J Viral Hepat. 2017 Feb 17. doi: 10.1111/jvh.12697.
    PubMed     Text format     Abstract available


    J Virol

  13. BELOUZARD S, Danneels A, Feneant L, Seron K, et al
    Correction for Belouzard et al., "Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes".
    J Virol. 2018;92.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  14. NEWSOME PN, Fox R, Forbes SJ
    Haematopoietic stem cells in cirrhosis - Authors' reply.
    Lancet Gastroenterol Hepatol. 2018;3:298-299.
    PubMed     Text format    


    PLoS One

  15. OKUBO H, Ando H, Sorin Y, Nakadera E, et al
    Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C.
    PLoS One. 2018;13:e0196747.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  16. SOLUND C, Hallager S, Pedersen MS, Fahnoe U, et al
    Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation.
    Scand J Gastroenterol. 2018 May 2:1-8. doi: 10.1080/00365521.2018.1467963.
    PubMed     Text format     Abstract available


    Transplant Proc

  17. IMAI H, Kamei H, Onishi Y, Ishizu Y, et al
    Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
    Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30211.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: